The seamless, hands-off workflow and automated analysis of IsoPlexis' instrumentation is designed to deliver actionable ‘omics data to accelerate pathway discoveries while bridging them to real-time, in vivo biological activity. In addition to offering single-cell solutions for measuring proteomes, metabolomes, and secretomes, the Connecticut-based company in early September unveiled its multi-omic solution Duomic, which simultaneously measures functional protein and gene expression levels from the same cell . . .

IsoPlexis Wraps Functional Single-Cell Proteomics in a Bow
CEO Sean Mackay on how his newly public life science technology company is driving the convergence of dynamic proteomics and single-cell biology to accelerate curative medicines.
IsoPlexis CEO and co-founder Sean Mackay discusses with GEN Edge how his company has developed a single cell proteomics platform designed to reveal a more complete view of protein function at an individual cellular level, providing an end-to-end solution for users that includes IsoLight and IsoSpark instruments designed for use as fully-automated benchtop proteomic hubs (pictured); IsoCode and CodePlex chip consumables and IsoSpeak software. [IsoPlexis]